Practo, the Bengaluru-based healthtech platform preparing for a public listing, has appointed Srijesh Kumar as its global chief product and technology officer (CPTO), according to Inc42 Media. The move comes as the company targets a $100 million to $125 million pre-IPO funding round—described as a mix of equity and debt—and accelerates its integration of AI across its platform to improve care delivery, patient experience, and provider tools.
The appointment is part of Practo’s operational preparations for a public listing. The company is now expected to go public in 2027, after earlier targeting a listing this year. The CPTO hire signals how Practo plans to connect product execution with technology delivery as it scales globally and expands AI-driven workflows.
CPTO Role and Kumar’s Background
Kumar will lead the product and technology teams, with a focus on helping the platform grow as it scales globally. According to the announcement, his role involves bringing product and technology together, improving the platform, and using healthcare data to build “better and more consistent solutions.”
Kumar brings over two decades of experience building enterprise-scale platforms. He served as a vice president at Salesforce, where he led product engineering for industries cloud. Prior roles include leadership positions at Expedia Group and Punchh, with earlier experience at Adobe and Microsoft.
The CPTO structure aligns roadmap decisions (what features to build) with system decisions (how to build and scale them). This coordination is particularly relevant as Practo expands its use of healthcare data and AI across its platform.
AI Integration and Data Scale
Practo is accelerating integration of AI to improve care delivery, patient experience, and provider tools. Last month, the company appointed Cijo George as vice president of AI to lead its AI strategy across the platform.
Practo’s platform operates at significant scale. The company audited over 1,000 healthcare establishments and processed more than 4 crore clinical data points in FY25. The platform connects users with over 7 lakh doctors and healthcare providers and expanded its network to over 1.5 lakh hospitals.
The platform includes multiple patient and provider touchpoints: users can find doctors, book consultations, order medicines, and schedule diagnostic tests. On the provider side, Practo offers SaaS tools for clinics and hospitals, including appointment management and digital health records. The company also operates Insta, its hospital management system, used by more than 500 clients across 1,200+ facilities globally.
Pre-IPO Funding and Financial Performance
Practo seeks to raise $100 million to $125 million in a pre-IPO funding round expected to be a mix of equity and debt. The round is likely to be led by a global private equity firm, with participation from existing investors, at a reported valuation of around $700 million.
The company plans to use the fresh capital to fund expansion and acquisitions. According to sources cited by Inc42, Practo’s revenue grew approximately 35% year-over-year in FY26, translating to about ₹315 crore. The company reported operating EBITDA of ₹15 crore on revenue of ₹234 crore in FY25, compared to an EBITDA loss of ₹17 crore in FY24.
Global Expansion and Company Background
Practo continues to scale in India while expanding into international markets including the US and the UAE. Global expansion introduces differences in workflows, systems integration, and data handling needs—areas where product and technology leadership influence standardization efforts.
Founded in 2008 by Shashank ND and Abhinav Lal, Practo has raised nearly $230 million to date from investors including Tencent, Peak XV Partners, Z47 Partners, and Sofina.
Why it matters: The CPTO appointment, the stated acceleration of AI integration, and the pre-IPO funding plan indicate Practo is coordinating product delivery and technology execution as it increases both global scale and AI-driven functionality. As Practo moves toward a 2027 public listing, the company’s ability to connect AI strategy to platform components that handle patient and provider workflows, and whether its data scale translates into measurable product improvements, will be areas to monitor.
Source: Inc42 Media